White label – Pompe disease - ClinicalTrials.eu

Study Comparing Ensartinib and Crizotinib for Patients with ALK-Positive Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
- X-396
- Crizotinib
+1
Study on the Safety and Effectiveness of Fianlimab, Cemiplimab, and Chemotherapy in Adults with Resectable Non-Small Cell Lung Cancer

Not recruiting

2 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
Safety Study of 5-Aminolevulinic Acid for Brain Tumor Surgery in Children and Adolescents

Not recruiting

2 1 1 1
Investigated Diseases:
- Brain neoplasm
Investigated Drugs:
- Aminolevulinic Acid Hydrochloride
Study on Daratumumab, Lenalidomide, and Dexamethasone for Patients with Primary Plasma Cell Leukemia

Not recruiting

2 1 1 1
Investigated Diseases:
- Plasma cell leukaemia
Investigated Drugs:
Study on the Effects of Tafamidis in Patients with Transthyretin Cardiac Amyloidosis

Not recruiting

3 1 1 1
Investigated Diseases:
- Cardiac amyloidosis
Investigated Drugs:
- Tafamidis
Study on Palbociclib and Drug Combination for Patients with Hormone Receptor Positive, HER2-Positive Metastatic Breast Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Breast cancer
Investigated Drugs:
Study on De-escalated Induction Therapy with Methotrexate, Cytarabine, Thiotepa, and Rituximab for Newly Diagnosed Primary CNS Lymphoma Patients

Not recruiting

3 1 1 1
Investigated Diseases:
- Central nervous system lymphoma
Investigated Drugs:
Study on Bevacizumab Injections for Patients with Coats’ Disease

Not recruiting

2 1 1 1
Investigated Diseases:
- Exudative retinopathy
Investigated Drugs:
- Bevacizumab
Study on Mosunetuzumab and Lenalidomide for Patients with Follicular Lymphoma After Previous Treatment

Not recruiting

3 1 1 1
Study on Tebentafusp and Drug Combination for Patients with Advanced Uveal Melanoma

Not recruiting

2 1 1 1
Investigated Diseases:
- Malignant melanoma
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies